BFC Planning’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$660 Buy
+27
New +$752 ﹤0.01% 3246

Other funds holding BEAM

BFC Planning's BEAM Position: Q3 2026 in Review

BFC Planning opened a new position in Beam Therapeutics (BEAM) in Q3 2026: 27 shares worth $660. The stake represents ﹤0.01% of the portfolio and ranks #3246 among its holdings.

191 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.

  • BFC Planning held 27 shares of Beam Therapeutics worth $660 as of Q3 2026.
  • Beam Therapeutics was a new BFC Planning position in Q3 2026.
  • Beam Therapeutics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3246 holding.
  • 191 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.